Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7306 AL 7320

Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias

Breithaupt AG, Tang A, Paolillo EW, Bibars M, Johnson ECB, Saloner R, Possin KL, Windon CC, Hill-Jarrett TG, Giorgio J, Rauschecker AM, Kwon H, Vonk JMJ, Pinheiro-Chagas P.

Semin Neurol. 2026 Feb;46(1):105-116. doi: 10.1055/a-2744-9871. Epub 2025 Nov 28.

Precision therapeutics for Alzheimer's disease

Priyanka S, Manjari T, Hemalatha S, Ambika S, Yılmaz B, Aktürk B, Arısan ED, Kumari A, Manojkumar Y.

Prog Brain Res. 2025;297:247-276. doi: 10.1016/bs.pbr.2025.08.011. Epub 2025 Sep 11.

Neurobiotech innovative strategies targeting Alzheimer's disease through therapeutic micro and macroalgae potentials

Wagdy M, Ibrahim AA, Yahia AM, Maher RM, Abo-Elwafa AH, Salah A, Heikal YM.

J Neuroimmunol. 2026 Feb;411:578821. doi: 10.1016/j.jneuroim.2025.578821. Epub 2025 Nov 25.

Decoding senescent drivers in Alzheimer's disease: From bench to bedside

Zhou R, Lin X, Liao Z, Lin J, Zheng R, Ni H, Liu W, Feng Z, He Q, Lin X, Tang C, Song J, Ning W.

Ageing Res Rev. 2026 Jan;114:102978. doi: 10.1016/j.arr.2025.102978. Epub 2025 Dec 2.

Alzheimer's Disease: The Current and Emerging Treatment Approaches

Pang R, Jia Q, Ma C, Li T, Bi W, Wang H, Liu R, Chen P, Lee ES, Jiang HB.

Behav Neurol. 2025 Dec 7;2025:9627699. doi: 10.1155/bn/9627699. eCollection 2025.

Engineering exosomes for Alzheimer's disease: Multi-target therapeutic strategies from pathogenesis to clinical translation

Zhang Y, Li Z, Guan H, Qiu Z, Zou C.

Clin Transl Med. 2025 Dec;15(12):e70548. doi: 10.1002/ctm2.70548.

Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance

Huang YW, Chan HC, Khoo JY, Chan ML, Bender D, Ponnusamy VK, Belaidi AA, Ke LY.

Neurochem Int. 2026 Jan;192:106104. doi: 10.1016/j.neuint.2025.106104. Epub 2025 Dec 14.

Role of tRNA-Derived Fragments and Their Modifications in the Pathogenesis and Treatment of Alzheimer's Disease

Li L, Kong J, Fan R, Yuan Y, Zhu L.

Mol Neurobiol. 2025 Dec 22;63(1):321. doi: 10.1007/s12035-025-05603-z.

APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer's Disease and Cardiovascular Disease

Liu C, Liu J, Wang YY, Xu SF, Yu LM.

Mol Neurobiol. 2025 Dec 23;63(1):325. doi: 10.1007/s12035-025-05629-3.

The evolving landscape of Alzheimer's disease therapy: From Aβ to tau

Courade JP, Zetterberg H, Höglinger GU, Dewachter I.

Cell. 2025 Dec 24;188(26):7337-7354. doi: 10.1016/j.cell.2025.11.033.

Deep cervical lymphaticovenous anastomosis for Alzheimer's disease: A narrative review

Chen Q, Wen Q, Zhong T, Liu J, Gao H.

Alzheimers Dement. 2025 Dec;21(12):e71038. doi: 10.1002/alz.71038.

Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;151:303-365. doi: 10.1016/bs.apcsb.2025.10.007. Epub 2025 Nov 7.

Patient Preferences for Dementia Interventions: A Scoping Review With a Systematic Review of Medications and Choice-Based Methods

Gupta R, Lin S, DiStefano MJ, Woo HYJ, Mao E, Wilson R, Amjad H, Drabo EF, Segal JB.

J Am Geriatr Soc. 2026 Mar;74(3):868-882. doi: 10.1111/jgs.70209. Epub 2025 Nov 26.

Active Immunization Targeting Amyloid β for the Treatment of Alzheimer's Disease

Triplett O, Varda N, Decourt B, Vasconcellos R, Sabbagh MN.

Neurodegener Dis. 2025;25(4):202-217. doi: 10.1159/000546287. Epub 2025 May 10.

Dendrimers: Patents for Alzheimer's Disease

Maheshwari S, Singh A.

Recent Pat Nanotechnol. 2025;19(3):356-363. doi: 10.2174/1872210517666230831154408.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias